OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
8.28
-0.10 (-1.19%)
At close: Oct 9, 2026, 4:00 PM EDT
8.30
+0.02 (0.24%)
After-hours: Oct 9, 2026, 7:30 PM EDT
OptimizeRx Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, OptimizeRx stock has a consensus rating of "Strong Buy" and an average price target of $12.6. The average 1-year stock price forecast is 52.17% higher than the current stock price, while the lowest is $11 (+32.85%) and the highest is $18 (+117.39%).
Price Target: $12.6 (+52.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for OptimizeRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 2, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +32.85% | Sep 29, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $18 | Buy | Maintains | $18 | +117.39% | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $11 | Buy | Maintains | $11 | +32.85% | Aug 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +44.93% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
96.23M
from 109.43M
Decreased by -12.06%
Revenue Next Year
106.60M
from 96.23M
Increased by 10.77%
EPS This Year
0.88
from 1.05
Decreased by -16.57%
EPS Next Year
1.04
from 0.88
Increased by 19.18%
EPS and Forward PE are based on non-GAAP adjusted numbers.